In a study by Tien et al., it was observed that CT-based radiomics predicted the KRAS/NRAS/BRAF mutations while clinical background, tumor stage and histological grade had no significant association (AUC 0.8) (14). The gene discussed is KRAS; the disease is neoplasm.